Global Organoids and Spheroids 麻豆原创 Research Report 2023

Publication ID:

PB502231259

Publication Date:

February 15, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Organoids are complex clusters of organ-specific cells such as stem cells or progenitor cells. Spheroids are simple clusters of broad-ranging cells such as tumor tissue, embryoid bodies.
Highlights
The global Organoids and Spheroids market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Organoids and Spheroids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Organoids and Spheroids is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Organoids and Spheroids in Biotechnology and Pharmaceutical Industries is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Organoids and Spheroids include Merck KGaA, ATCC, Corning Incorporated, Greiner Bio-One(Greiner Group AG), AMS Biotechnology (Europe) Limited, Lonza, Hubrecht Organoid Technology (HUB), 3D Biomatrix and 3D Biotek LLC, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Organoids and Spheroids, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organoids and Spheroids.
The Organoids and Spheroids market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Organoids and Spheroids market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organoids and Spheroids companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Merck KGaA
ATCC
Corning Incorporated
Greiner Bio-One(Greiner Group AG)
AMS Biotechnology (Europe) Limited
Lonza
Hubrecht Organoid Technology (HUB)
3D Biomatrix
3D Biotek LLC
Cellesce Ltd.
Prellis Biologics
STEMCELL Technologies Inc.
Thermo Fisher Scientific Inc.
Segment by Type
by Organoids Type
Neural Organoids
Hepatic Organoids
Intestinal Organoids
Others
by Spheroids Type
Multicellular Tumor Spheroids (MCTS)
Neurospheres
Mammospheres
Hepatospheres
Embryoid Bodies
Segment by Application
Biotechnology and Pharmaceutical Industries
Academic and Research Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organoids and Spheroids companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Organoids Type
1.2.1 Global Organoids and Spheroids 麻豆原创 Size Growth Rate by Organoids Type: 2018 VS 2022 VS 2029
1.2.2 Neural Organoids
1.2.3 Hepatic Organoids
1.2.4 Intestinal Organoids
1.2.5 Others
1.3 麻豆原创 by Application
1.3.1 Global Organoids and Spheroids 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Biotechnology and Pharmaceutical Industries
1.3.3 Academic and Research Institutes
1.3.4 Hospitals and Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organoids and Spheroids 麻豆原创 Perspective (2018-2029)
2.2 Organoids and Spheroids Growth Trends by Region
2.2.1 Global Organoids and Spheroids 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Organoids and Spheroids Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Organoids and Spheroids Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Organoids and Spheroids 麻豆原创 Dynamics
2.3.1 Organoids and Spheroids Industry Trends
2.3.2 Organoids and Spheroids 麻豆原创 Drivers
2.3.3 Organoids and Spheroids 麻豆原创 Challenges
2.3.4 Organoids and Spheroids 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organoids and Spheroids Players by Revenue
3.1.1 Global Top Organoids and Spheroids Players by Revenue (2018-2023)
3.1.2 Global Organoids and Spheroids Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Organoids and Spheroids 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Organoids and Spheroids Revenue
3.4 Global Organoids and Spheroids 麻豆原创 Concentration Ratio
3.4.1 Global Organoids and Spheroids 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organoids and Spheroids Revenue in 2022
3.5 Organoids and Spheroids Key Players Head office and Area Served
3.6 Key Players Organoids and Spheroids Product Solution and Service
3.7 Date of Enter into Organoids and Spheroids 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Organoids and Spheroids Breakdown Data by Type
4.1 Global Organoids and Spheroids Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Organoids and Spheroids Forecasted 麻豆原创 Size by Type (2024-2029)
5 Organoids and Spheroids Breakdown Data by Application
5.1 Global Organoids and Spheroids Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Organoids and Spheroids Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Organoids and Spheroids 麻豆原创 Size (2018-2029)
6.2 North America Organoids and Spheroids 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Organoids and Spheroids 麻豆原创 Size by Country (2018-2023)
6.4 North America Organoids and Spheroids 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organoids and Spheroids 麻豆原创 Size (2018-2029)
7.2 Europe Organoids and Spheroids 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Organoids and Spheroids 麻豆原创 Size by Country (2018-2023)
7.4 Europe Organoids and Spheroids 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organoids and Spheroids 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Organoids and Spheroids 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Organoids and Spheroids 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Organoids and Spheroids 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organoids and Spheroids 麻豆原创 Size (2018-2029)
9.2 Latin America Organoids and Spheroids 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Organoids and Spheroids 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Organoids and Spheroids 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organoids and Spheroids 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Organoids and Spheroids 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Organoids and Spheroids 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Organoids and Spheroids 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Company Detail
11.1.2 Merck KGaA Business Overview
11.1.3 Merck KGaA Organoids and Spheroids Introduction
11.1.4 Merck KGaA Revenue in Organoids and Spheroids Business (2018-2023)
11.1.5 Merck KGaA Recent Development
11.2 ATCC
11.2.1 ATCC Company Detail
11.2.2 ATCC Business Overview
11.2.3 ATCC Organoids and Spheroids Introduction
11.2.4 ATCC Revenue in Organoids and Spheroids Business (2018-2023)
11.2.5 ATCC Recent Development
11.3 Corning Incorporated
11.3.1 Corning Incorporated Company Detail
11.3.2 Corning Incorporated Business Overview
11.3.3 Corning Incorporated Organoids and Spheroids Introduction
11.3.4 Corning Incorporated Revenue in Organoids and Spheroids Business (2018-2023)
11.3.5 Corning Incorporated Recent Development
11.4 Greiner Bio-One(Greiner Group AG)
11.4.1 Greiner Bio-One(Greiner Group AG) Company Detail
11.4.2 Greiner Bio-One(Greiner Group AG) Business Overview
11.4.3 Greiner Bio-One(Greiner Group AG) Organoids and Spheroids Introduction
11.4.4 Greiner Bio-One(Greiner Group AG) Revenue in Organoids and Spheroids Business (2018-2023)
11.4.5 Greiner Bio-One(Greiner Group AG) Recent Development
11.5 AMS Biotechnology (Europe) Limited
11.5.1 AMS Biotechnology (Europe) Limited Company Detail
11.5.2 AMS Biotechnology (Europe) Limited Business Overview
11.5.3 AMS Biotechnology (Europe) Limited Organoids and Spheroids Introduction
11.5.4 AMS Biotechnology (Europe) Limited Revenue in Organoids and Spheroids Business (2018-2023)
11.5.5 AMS Biotechnology (Europe) Limited Recent Development
11.6 Lonza
11.6.1 Lonza Company Detail
11.6.2 Lonza Business Overview
11.6.3 Lonza Organoids and Spheroids Introduction
11.6.4 Lonza Revenue in Organoids and Spheroids Business (2018-2023)
11.6.5 Lonza Recent Development
11.7 Hubrecht Organoid Technology (HUB)
11.7.1 Hubrecht Organoid Technology (HUB) Company Detail
11.7.2 Hubrecht Organoid Technology (HUB) Business Overview
11.7.3 Hubrecht Organoid Technology (HUB) Organoids and Spheroids Introduction
11.7.4 Hubrecht Organoid Technology (HUB) Revenue in Organoids and Spheroids Business (2018-2023)
11.7.5 Hubrecht Organoid Technology (HUB) Recent Development
11.8 3D Biomatrix
11.8.1 3D Biomatrix Company Detail
11.8.2 3D Biomatrix Business Overview
11.8.3 3D Biomatrix Organoids and Spheroids Introduction
11.8.4 3D Biomatrix Revenue in Organoids and Spheroids Business (2018-2023)
11.8.5 3D Biomatrix Recent Development
11.9 3D Biotek LLC
11.9.1 3D Biotek LLC Company Detail
11.9.2 3D Biotek LLC Business Overview
11.9.3 3D Biotek LLC Organoids and Spheroids Introduction
11.9.4 3D Biotek LLC Revenue in Organoids and Spheroids Business (2018-2023)
11.9.5 3D Biotek LLC Recent Development
11.10 Cellesce Ltd.
11.10.1 Cellesce Ltd. Company Detail
11.10.2 Cellesce Ltd. Business Overview
11.10.3 Cellesce Ltd. Organoids and Spheroids Introduction
11.10.4 Cellesce Ltd. Revenue in Organoids and Spheroids Business (2018-2023)
11.10.5 Cellesce Ltd. Recent Development
11.11 Prellis Biologics
11.11.1 Prellis Biologics Company Detail
11.11.2 Prellis Biologics Business Overview
11.11.3 Prellis Biologics Organoids and Spheroids Introduction
11.11.4 Prellis Biologics Revenue in Organoids and Spheroids Business (2018-2023)
11.11.5 Prellis Biologics Recent Development
11.12 STEMCELL Technologies Inc.
11.12.1 STEMCELL Technologies Inc. Company Detail
11.12.2 STEMCELL Technologies Inc. Business Overview
11.12.3 STEMCELL Technologies Inc. Organoids and Spheroids Introduction
11.12.4 STEMCELL Technologies Inc. Revenue in Organoids and Spheroids Business (2018-2023)
11.12.5 STEMCELL Technologies Inc. Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Detail
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Organoids and Spheroids Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Organoids and Spheroids Business (2018-2023)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Merck KGaA
ATCC
Corning Incorporated
Greiner Bio-One(Greiner Group AG)
AMS Biotechnology (Europe) Limited
Lonza
Hubrecht Organoid Technology (HUB)
3D Biomatrix
3D Biotek LLC
Cellesce Ltd.
Prellis Biologics
STEMCELL Technologies Inc.
Thermo Fisher Scientific Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.